AUPH AURINIA PHARMACEUTICALS INC

Ownership history in XTX Topco Ltd  ·  9 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in AURINIA PHARMACEUTICALS INC (AUPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2022 Q4)
Avg. % of fund
0.04%
First filed
2022 Q2
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 21,686 -84,749 -79.6% 0.01% $240K $11.05
2025 Q1 ADDED 106,435 +63,681 +148.9% 0.04% $856K $8.04
2024 Q4 ADDED 42,754 +19,263 +82.0% 0.03% $384K $8.98
2024 Q1 REDUCED 23,491 -770 -3.2% 0.02% $118K $5.01
2023 Q3 ADDED 24,261 +10,700 +78.9% 0.03% $189K $7.77
2023 Q2 REDUCED 13,561 -54,982 -80.2% 0.02% $131K $9.68
2022 Q4 ADDED 68,543 +35,790 +109.3% 0.06% $296K $4.32
2022 Q3 ADDED 32,753 +19,502 +147.2% 0.06% $246K $7.52
2022 Q2 INITIATED 13,251 0.05% $133K $10.05
% of Fund (quarterly)    AUPH price (monthly, adj. close)
← Back to XTX Topco Ltd Holdings